Delivery Order SPE2DB20D1110-SPE2DB25FJ94A

Award Date 2/10/25
Potential Completion Date 2/11/25
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of LYRICA 75 MG CAPSULE 90S to the Defense Logistics Agency (DLA), a defense agency. The $3,847.45 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of October 30, 2024. Amerisourcebergen is the prime contractor and holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
This federal contract award is for the delivery of Lyrica 300mg capsules to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on January 28, 2025 with a ceiling value of $1,918.65. The contract is a Firm Fixed Price Delivery Order with a completion date of January 29, 2025. This contract is not designated as a set-aside award....
This federal contract award is for the delivery of Lyrica 150 mg capsules to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,998.84 and was awarded on November 16, 2021, with a completion date of November 17, 2021. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen Drug Corp's parent...
This federal contract award is for the delivery of Lyrica 25 mg capsules to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on March 25, 2024. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,079.64 and an ultimate completion date of March 26, 2024. The contract is not designated with a set-aside...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide LYRICA 50 MG CAPSULE 90S medication. The contract, valued at $2,394.99, has a completion date of March 1, 2024. Amerisourcebergen Drug Corp serves as the prime contractor, providing pharmaceutical products and medical supplies to DLA Troop Support Medical to support military treatment programs and facilities. This...
This federal contract award is for the delivery of Lyrica 50 mg capsules to the Defense Logistics Agency (DLA). The contract, valued at $1,905.99, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 16, 2024. The contract has an ultimate completion date of October 17, 2024 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of Lyrica 150 mg capsules in quantities of 90s to the U.S. government. The $1,146.90 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a delivery order issued under Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,345.64 to Amerisourcebergen Drug Corp, the prime contractor, to provide LYRICA 100 MG CAPSULE 90S. This contract supports DLA Troop Support Medical's mission to supply pharmaceuticals and medical materials to military treatment programs and facilities. Amerisourcebergen Drug Corp, a for-profit organization and subsidiary of Amerisourcebergen Corporation, holds an Indefinite Delivery Contract (IDC) with...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, to provide LYRICA 300 MG CAPSULE 90S. The order has a completion date of February 6, 2024 and a potential value of $1,644.48. This award is issued under a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA, which serves as the...
The Defense Logistics Agency (DLA) awarded a $12,371.13 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide LYRICA 25 MG CAPSULE 90S. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as the primary contract vehicle for Amerisourcebergen Drug Corp to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities...
  • SPE2DB20D1110
    Indefinite Delivery Contract
  • SPE2DB20D1110-SPE2DB25FJ94A
    Delivery Order

This federal contract award is for the delivery of LYRICA 150 MG CAPSULE 90S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,290.52 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 10, 2025, with a completion date of February 11, 2025. The contract is a delivery order under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/12/25, 9:49 AM